Role of the microenvironment in chronic lymphocytic leukaemia.
about
Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivoImmunological aspects in chronic lymphocytic leukemia (CLL) developmentDecreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factorCXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulationBone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cellsThe novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.Targeted treatment for chronic lymphocytic leukemia.Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1).CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialTargeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alphaAMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.Microenvironmental interactions and survival of CLL B-cells.The immunoglobulin genes and chronic lymphocytic leukemia (CLL).Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia.Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cellsThe CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemiaGranulocyte colony-stimulating factor inhibits CXCR4/SDF-1α signaling and overcomes stromal-mediated drug resistance in the HL-60 cell lineB-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistanceHsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progressionThe microenvironment in mature B-cell malignancies: a target for new treatment strategiesCAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia.Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.Inflammation and survival pathways: chronic lymphocytic leukemia as a model system.Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function.Midkine as a regulator of B cell survival in health and disease.Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.Dissecting chronic lymphocytic leukemia microenvironment signals in patients with unmutated disease: microRNA-22 regulates phosphatase and tensin homolog/AKT/FOXO1 pathway in proliferative leukemic cells.The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells
P2860
Q24305423-9D8CD1FA-8175-40FA-83EC-E9CDE86F4537Q26865940-D591FCD2-F904-4D41-91FF-EBCD30435895Q33654957-B513786D-639F-4423-A62E-1F4C97549F75Q33829089-B42D556C-3321-4CB4-8D99-FED8B9AF55CCQ33875604-DE8272B6-D40F-4E98-8396-DBC49BC6E4EFQ35061209-ADD68905-81B8-4929-BEE9-6E20DD435A7DQ35136736-89DD978D-6E8A-4538-A907-DEE3979FBF2DQ35584788-92D35B57-CE90-42B6-A5A9-A9FC405C3B37Q35599741-F3C68753-C40E-4BE0-AB4C-047EB3C774C5Q35718966-0395FDF6-CDAC-49AE-925F-290C720D4FE0Q35769292-E2AB9C2F-F841-4B52-8527-84874AA71642Q35776992-2516DBB2-927D-42CF-9259-97A761EC2226Q35847913-813E34DE-0605-43C3-9DDB-3808AF1C89C5Q35944653-227A05B0-C18E-4995-A559-60190A17B266Q35994836-FF46D891-AFD6-4AD6-91B0-1F0D21C41E7BQ36216608-1D6A7C46-7364-43D8-B925-92DE3E38E1C7Q36635059-7FD865C9-9A93-4684-9EE1-968FBA1D729DQ36776849-E9AE03C2-6F2C-4765-AE85-BE1B19CE02E0Q36787532-74B81052-2F24-4150-B134-EB93B4B867AFQ36800490-2A0A3849-6E21-4538-8DD5-C15B4F54339DQ36942667-10AAAC46-A6CC-47F6-BF0E-29C3BEDFA344Q37001216-6DF86B2A-5569-4405-8992-B7339D63B542Q37028635-F99BB512-8E96-4287-B149-5A89F5B196B2Q37039117-06235302-74F2-4ADA-8346-D062445D881BQ37417412-DB71A9D0-3C59-4587-A39D-68D6EAA56B34Q37439573-DC05A1B4-116B-46C1-9A6A-F97B0826C6A0Q37563816-EEE8ED6E-2D18-444E-B55E-CDF0B4E17995Q37587956-35F6214A-0550-4364-A34E-B393A7F54F19Q37588785-1D01E57C-9C9B-436B-B1E0-282463C9ED52Q37694914-9BCE1973-A0B6-483B-8F8A-1092AAE34B1CQ37771664-7D0E7CC7-836B-4640-8B2E-436899D0E592Q37778876-8DC688D2-4FFB-48FC-81F8-A8C518A58563Q37971736-3874817F-3F21-4281-B570-BE58704F1B4FQ37983913-E793CE88-BBEB-494E-9602-B2623212E3E9Q37998010-046A3353-4994-40E8-9E0E-0675011AAE2FQ38151163-6305ECAD-8FF9-46B2-AD40-9BC7936603ECQ38325527-611B73F6-4EB1-47B9-BCEA-D31B0EE6DBDBQ38937322-0FB1418D-6145-4274-AB9B-086A22E24498Q39404177-D2704643-22F7-4116-AB94-2F2BD78049E6Q39433259-5B577AC3-B4F0-4437-A32A-7A5BA28A35AE
P2860
Role of the microenvironment in chronic lymphocytic leukaemia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Role of the microenvironment in chronic lymphocytic leukaemia.
@ast
Role of the microenvironment in chronic lymphocytic leukaemia.
@en
type
label
Role of the microenvironment in chronic lymphocytic leukaemia.
@ast
Role of the microenvironment in chronic lymphocytic leukaemia.
@en
prefLabel
Role of the microenvironment in chronic lymphocytic leukaemia.
@ast
Role of the microenvironment in chronic lymphocytic leukaemia.
@en
P1476
Role of the microenvironment in chronic lymphocytic leukaemia.
@en
P2093
Federico Caligaris-Cappio
P304
P356
10.1046/J.1365-2141.2003.04679.X
P407
P577
2003-11-01T00:00:00Z